2689.T JPX
OLBA HEALTHCARE HOLDINGS, Inc.
1W: +0.3%
1M: +2.9%
3M: +1.5%
YTD: -8.8%
1Y: -7.5%
3Y: +18.7%
5Y: +35.5%
¥1,930.00 ($12.23)
+7.00 (+0.36%)
Weekly Expected Move ±2.0%
¥1853
¥1891
¥1930
¥1969
¥2007
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$122.7B
+3.5% ▲
5Y CAGR: +2.6%
Gross Profit
$13.9B
+2.3% ▲
5Y CAGR: +4.7%
Operating Income
$2.0B
-11.1% ▼
5Y CAGR: +16.4%
Net Income
$1.4B
-4.7% ▼
5Y CAGR: +34.4%
EPS (Diluted)
$241.43
-4.1% ▼
5Y CAGR: +33.6%
EBITDA
$2.6B
-8.3% ▼
5Y CAGR: +17.5%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $113.0B | $108.0B | $110.5B | $118.6B | $122.7B |
| YoY Growth | +4.7% | -4.4% | +2.3% | +7.3% | +3.5% |
| Cost of Revenue | $101.4B | $95.5B | $97.5B | $105.0B | $108.8B |
| Gross Profit | $11.6B | $12.5B | $13.0B | $13.6B | $13.9B |
| Gross Margin | 10.3% | 11.6% | 11.7% | 11.5% | 11.3% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $10.1B | $10.4B | $10.8B | $11.4B | $11.9B |
| Operating Expenses | $10.1B | $10.4B | $10.8B | $11.4B | $11.9B |
| Operating Income | $1.5B | $2.1B | $2.2B | $2.2B | $2.0B |
| Operating Margin | 1.4% | 1.9% | 1.9% | 1.9% | 1.6% |
| Interest Expense | $22M | $21M | $18M | $19M | $38M |
| Income Before Tax | $1.5B | $2.1B | $2.2B | $2.2B | $1.9B |
| Tax Expense | $524M | $601M | $742M | $743M | $490M |
| Net Income | $989M | $1.5B | $1.4B | $1.5B | $1.4B |
| Net Margin | 0.9% | 1.4% | 1.3% | 1.3% | 1.2% |
| EPS (Diluted) | $162.66 | $252.80 | $234.90 | $251.68 | $241.43 |
| EBITDA | $1.9B | $2.6B | $2.7B | $2.8B | $2.6B |
| Shares Outstanding | 6M | 6M | 6M | 6M | 6M |